AHA GUIDELINES Bundle (free trial)

ACCF/AHA Device-Based Therapy Guidelines

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/112380

Contents of this Issue

Navigation

Page 7 of 19

Diagnosis and Treatment Permanent Pacing in Hypersensitive Carotid Sinus Syndrome and Neurocardiogenic Syncope Key Points ����The hypersensitive carotid sinus syndrome is defined as syncope or presyncope resulting from an extreme reflex response to carotid sinus stimulation. There are 2 components of the reflex: ������ Cardioinhibitory, which results from increased parasympathetic tone and is manifested by slowing of the sinus rate or prolongation of the PR interval and advanced AV block, alone or in combination. ������ Vasodepressor, which is secondary to a reduction in sympathetic activity that results in loss of vascular tone and hypotension. This effect is independent of heart rate changes. ����Hyperactive response to carotid sinus stimulation is defined as asystole due to either sinus arrest or AV block of >3 seconds, a substantial symptomatic decrease in systolic blood pressure, or both. ����Permanent pacing for patients with an excessive cardioinhibitory response to carotid stimulation is effective in relieving symptoms. ����Because 10%-20% of patients with this syndrome may have an important vasodepressive component of their reflex response, it is desirable that this component be defined before one concludes that all symptoms are related to asystole alone. Among patients whose reflex response includes both cardioinhibitory and vasodepressive components, attention to the latter is essential for effective therapy in patients undergoing pacing. Treatment ����Permanent pacing is indicated: ������ for recurrent syncope caused by spontaneously occurring carotid sinus stimulation and carotid sinus pressure that induces ventricular asystole of >3 seconds. (I-C) ����Permanent pacing is reasonable for: ������ syncope without clear, provocative events and with a hypersensitive cardioinhibitory response of ���3 seconds. (IIa-C) ����Permanent pacing may be considered for: ������ significantly symptomatic neurocardiogenic syncope associated with bradycardia documented spontaneously or at the time of tilt-table testing. (IIb-B) ����Permanent pacing is NOT indicated for: ������ a hypersensitive cardioinhibitory response to carotid sinus stimulation without symptoms or with vague symptoms. (III-C) ������ situational vasovagal syncope in which avoidance behavior is effective and preferred. (III-C) 6

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - ACCF/AHA Device-Based Therapy Guidelines